Mat Sheedy

Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada

Mylan API, Inc. engages in manufacturing and development of Active Pharmaceutical Ingredients. The company was founded in 2014 and is headquartered in Somerset, NJ.

Magellan Biotech, Inc. provides private equity services to biotechnology companies.

Part of The Hong Kong University of Science & Technology, Biotechnology Research Corp. engages in biotechnology research and development. The company is based in Hong Kong, Hong Kong.

Genesys Venture, Inc. operates as an investment firm, which specializes in health and biotechnology ventures. It offers life science accelerator services such as start-up, early-mid stage capitalization, business development, technology development, intellectual property management, and accounting and finance. The company was founded by Albert D. Friesen and Dawson J. Reimer in 1997 and is headquartered in Winnipeg, Canada.

KAM Scientific, Inc. manufactures and distributes microbial disinfectant spray solutions for laboratories, hospitals, dental offices, clinics and various medical and public health related facilities. It offers Virocidin-X, a disinfectant and deodorizer for cleaning bacteria, fungus, and viruses. The company was founded by Albert D. Friesen and is headquartered in Winnipeg, Canada.

MEDA Investments, Inc. is a private equity firm located in Waterloo, Ontario with additional offices in Winnipeg, Manitoba and Lancaster, Pennsylvania. The firm is a subsidiary of the Mennonite Economic Development Associates, an association that invests in the lives of families living in poverty around the world. MEDA Investments is a member of the Aspen Network of Development Entrepreneurs (ANDE), Canada's Venture Capital and Private Equity Association (CVCA), the International Association of Microfinance Investors (IAMFI) and the Social Investment Organization (SIO). MEDA Investments is a socially responsible international development investment organization. Their activities include microfinance and various other small and medium sized investment sectors that benefit poor communities. The firm provides access to private capital from developed countries and channels it to effective and sustainable business solutions to end poverty in developing countries. Investments are made through the Sarona Risk Capital Fund, Microvest or the Sarona Frontier Markets Fund. MEDA Investments also intermediates direct investments or private placements for investors on a project basis.

Sensible Medical Innovations Ltd. develops non-invasive devices for monitoring congestive heart failures. The firm also developed an imaging method for internal organs based on information technology. The company was founded by Nadav Mizrahi, Amir Soroka, Dan Rappaport, Amir Ronen and Shlomi Bergida in 2007 and is headquartered in Netanya, Israel.

GVI Clinical Development Solutions, Inc. provides business consultancy services. The private company is based in Winnipeg, Canada.

Marsala Biotech, Inc. engages in the discovery and development of drugs for cancer treatment. It offers E10A technology, an investigational gene therapy agent that utilizes an adenovirus vector to deliver the endostatin gene. The company is headquartered in Winnipeg, Canada.